Joseph E Grossman

9PUBLICATIONS
102CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Apr 27, 2026
Cancer-associated fibroblasts regulate DNA repair in pancreatic cancer through NDRG1-mediated R-loop processing.

|Jan 27, 2025
Botensilimab (Fc-enhanced anti-cytotoxic lymphocyte-association protein-4 antibody) Plus Balstilimab (anti-PD-1 antibody) in Patients With Relapsed/Refractory Metastatic Sarcomas.

Breelyn A Wilky, Gary K Schwartz, Michael S Gordon

|Jul 31, 2024
Botensilimab, an Fc-Enhanced Anti-CTLA-4 Antibody, Is Effective against Tumors Poorly Responsive to Conventional Immunotherapy.

Dhan Chand, David A Savitsky, Shanmugarajan Krishnan

|Jun 13, 2024
Botensilimab plus balstilimab in relapsed/refractory microsatellite stable metastatic colorectal cancer: a phase 1 trial.

Andrea J Bullock, Benjamin L Schlechter, Marwan G Fakih

|Jan 28, 2024
Overcoming resistance to programmed cell death protein 1 (PD-1) blockade with allogeneic invariant natural killer T-cells (iNKT).

Matthew J Hadfield, Howard Safran, Marco A Purbhoo

|Apr 11, 2023
Accelerating the Evolution of Immune-Related Enterocolitis Management.

David M Faleck, Michael Dougan, Monique Tello

Pageof 2

Frequent Collaborators

3 joint publications

Bruno Bockorny

3 joint publications

Andrea J Bullock

3 joint publications

Justin Stebbing

3 joint publications

Chloe Delepine